Safety and immunogenicity of an investigational quadrivalent meningococcal CRM197 conjugate vaccine, MenACWY-CRM, compared with licensed vaccines in adults in Latin America | Zendy

Daniel Stamboulián | Zendy; Gustavo Lopardo | Zendy; Pío López | Zendy; Carlos Cortes-Barbosa | Zendy; Alejandra Valencia | Zendy; Lisa Bedell | Zendy; Annette Karsten | Zendy; Peter Dull | Zendy

Open Access

Safety and immunogenicity of an investigational quadrivalent meningococcal CRM197 conjugate vaccine, MenACWY-CRM, compared with licensed vaccines in adults in Latin America

Author(s) -

Daniel Stamboulián,

Gustavo Lopardo,

Pío López,

Carlos Cortes-Barbosa,

Alejandra Valencia,

Lisa Bedell,

Annette Karsten,

Peter Dull

Publication year - 2010

Publication title -

international journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.278

H-Index - 89

eISSN - 1878-3511

pISSN - 1201-9712

DOI - 10.1016/j.ijid.2010.03.017

Subject(s) - immunogenicity , medicine , latin americans , meningococcal vaccine , conjugate vaccine , virology , immunology , immunization , antigen , political science , law

This study compared the investigational quadrivalent meningococcal CRM₁₉₇ conjugate vaccine, MenACWY-CRM, with licensed quadrivalent polysaccharide (MPSV4) and conjugate (MenACWY-D) meningococcal vaccines.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research